§ Tim LoughtonTo ask the Secretary of State for health which drugs referred to NICE have been rejected and subsequently subjected to the appeal mechanism; and which of them were successfully approved. [83309]
§ Mr. Lammy[holding answer 25 November 2002]: In total 56 appraisals have reached the stage where an appeal could be received; of these 19 received appeals and seven of these were upheld, six relating to drugs. The thrust of the recommendations changed in one of the appraisals as a result of an appeal, namely Rituximab for follicular non-Hodgkins lymphoma.